期刊文献+

抗肿瘤活性物SYUIQ-5对大鼠肝组织细胞色素P450基因表达的影响 被引量:1

Effects of SYUIQ-5,a novel antitumor agent,on gene expression of hepatic cytochrome P-450 in rats
原文传递
导出
摘要 目的研究抗肿瘤活性物SYUIQ-5对大鼠肝组织细胞色素P(CYP)450基因表达的影响。方法抗肿瘤活性物SYUIQ-5,0.1mg/kg、5mg/kg、10mg/kg三个剂量,雄性SD大鼠经腹腔注射连续处理5d后,取肝组织,提取总RNA,应用反转录-聚合酶链反应(RT-PCR)检测CYP3A1、2B1/2、1A1、1A2和2E1信使核糖核酸(mRNA)的表达。结果与空白对照组相比,抗肿瘤活性物SYUIQ-5可显著诱导CYP1A1mRNA的表达,对CYP3A1、2B1/2、1A2和2E1mRNA表达无影响。结论抗肿瘤活性物SYUIQ-5可显著诱导大鼠肝组织CYP1A1基因表达,对CYP3A1、2B1/2、1A2和2E1的基因表达无影响。 Objective To study the effect of SYUIQ-5, a novel antitumor agent,on gene expression of hepatic cytoehrome P450 in rats. Methods Male Sprague-Dawley rats were administered daily intraperitoneal dose of SYUIQ-5(0. lmg/kg,5mg/kg and 10mg/kg body weight) for 5 consecutive days. The levels of CYP 3A1,2B1/2, 1A1,1A2 and 2E1 mRNA in rat liver were analyzed by reverse transeription-polymerase chain reaetion(RT-PCR). Results The level of gene expression of CYP 1A1 was increased significantly compared with the control. The levels of CYP 3A1,2B1/2,1A2 and 2E1 mRNA were not changed by SYUIQ-5 treatment compared with the control. Conclusion A significant increase in the CYP 1A1 rather than CYP3A1,2B1/2,1A2 and 2E1 gene expression by SYUIQ-5 treatment is observed.
出处 《中国基层医药》 CAS 2006年第5期721-722,共2页 Chinese Journal of Primary Medicine and Pharmacy
关键词 细胞色素P450酶系统 酶抑制剂 逆转录聚合酶链式反应 动物实验 Cytochrome P450 enzyme system Enzyme inhibitors Reverse transcriptase polymerase chain reaction Animal experimentation
  • 相关文献

参考文献5

  • 1Zhou JL,Lu YJ,Ou TM,et al.Synthesis and evaluation of quindoline derivatives as G-quadruplex inducing and stabilizing ligands and potential inhibitors of telomerase.J Med Chem,2005,48(23):7315-7321.
  • 2Zhou J M,Zhu XF,Lu Y J,et al.Senescence and telomere shortening induced by novel potent G-quadruplex interactive agents,quindoline derivatives,in human cancer cell lines.Oncogene,2006,25 (4):503-511.
  • 3Bjornsson TD,Callaghan JT,Einolf HJ,et al.The conduct of in vitro and in vivo drug-drug interaction studies:a pharmaceutical research and manufacturers of America (PhRMA) perspective.Drug Metab Dispos,2003,31 (7):815-832.
  • 4张慧锋,王月鹏,李妍.细胞色素P450的研究进展[J].吉林医药学院学报,2005,26(3):174-177. 被引量:24
  • 5Capdevila JH,Falck JR,Harris RC.Cytochrome P-450 and arachidonic acid bioactivation:molecular and functional properities of the arachidonate monooxygenase.J Lip Res,2000,41 (2):163-181.

二级参考文献5

共引文献23

同被引文献4

  • 1毕惠嫦,和凡,温莹莹,陈孝,黄民.丹参酮Ⅱ_A在大鼠肝微粒体酶中的代谢动力学[J].中草药,2007,38(6):882-886. 被引量:14
  • 2He F, Bi H C, Huang M, et al. Rapid determination of six metaboJhes from multiple cytochrome P450 probe substrates in human liver microsome by liquid chromatography/mass spectrometry: application to high-throughput screening for cytochrome P450 inhibition effect of terpenoids [J]. Rapid Commun Mass Spectrom, 2007, 21 : 635-643.
  • 3Deng Y, Bi H C, Zhao L Z, et al. Induction of cytochrome P450s by terpene trilactones and flavonids of the Ginkgo biloba extract EGb 761 in rats [J]. Xenobiotica, 2008, 38: 465-481.
  • 4梁勇,羊裔明,袁淑兰.丹参酮药理作用及临床应用研究进展[J].中草药,2000,31(4):304-306. 被引量:264

引证文献1

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部